Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
41 hedge funds and large institutions have $35.6M invested in Genocea Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.
159% more capital invested
Capital invested by funds: $13.7M → $35.6M (+$21.9M)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
5% less funds holding
Funds holding: 43 → 41 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$6.15M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.68M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.23M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$142K |
| 5 |
Renaissance Technologies
New York
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$943K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
-$230K |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$228K |
| 4 |
Millennium Management
New York
|
-$20K |
| 5 |
VF
Virtu Financial
New York
|
-$16K |
GNCA Hedge Fund Activity: Q1 2019 in Review
41 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2019, worth a combined $35.6M — up 159% from $13.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GNCA and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 9 added.
The largest buyer was NEA Management Company, adding an estimated $6.15M. The largest seller was Ghost Tree Capital, cutting an estimated $943K.
- 41 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2019, down from 43 in Q4 2018.
- Funds reported $35.6M of Genocea Biosciences, Inc. stock for Q1 2019, up 159% quarter-over-quarter.
- 5 funds opened new Genocea Biosciences, Inc. positions in Q1 2019 and 7 closed out, a net change of -2 holders.
- The largest Genocea Biosciences, Inc. buyer in Q1 2019 was NEA Management Company, an estimated $6.15M added.
- The largest Genocea Biosciences, Inc. seller in Q1 2019 was Ghost Tree Capital, an estimated $943K sold.
Based on aggregated 13F filings for Q1 2019.